Immunocore Holdings Future Growth

How is Immunocore Holdings forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

65.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:IMCR - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	281	35	49	61	4
12/31/2024	229	-7	14	56	8
12/31/2023	183	-12	9	13	9
9/30/2022	102	-55	-49	-48	N/A
6/30/2022	67	-92	-79	-78	N/A
3/31/2022	41	-119	-102	-101	N/A
12/31/2021	27	-132	-97	-96	N/A
9/30/2021	27	-111	-101	-100	N/A
6/30/2021	28	-100	-81	-79	N/A
3/31/2021	30	-84	-60	-57	N/A
12/31/2020	30	-74	-64	-61	N/A
9/30/2020	28	-81	-71	-66	N/A
6/30/2020	27	-88	-111	-106	N/A
3/31/2020	27	-97	-117	-114	N/A
12/31/2019	26	-104	-107	-103	N/A
12/31/2018	24	-72	-20	-17	N/A
12/31/2017	14	-49	-79	-61	N/A
12/31/2016	16	-23	-43	-37	N/A

Earnings vs Savings Rate: IMCR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: IMCR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IMCR is expected to become profitable in the next 3 years.

Revenue vs Market: IMCR's revenue (28.5% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: IMCR's revenue (28.5% per year) is forecast to grow faster than 20% per year.